| NCT ID | NCT07496424 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bruno Mora |
| Condition | Transesophageal Echocardiography |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-03-23 |
| Primary Completion | 2027-03-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2026-03-23 with a primary completion date of 2027-03-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Myocardial strain analysis provides additional and valuable information about left ventricular function, particularly in the perioperative setting with its dynamic changes in ventricular load conditions. This allows for earlier risk assessment and, if necessary, the initiation of faster and more targeted therapy. Unfortunately, conventional strain analysis using conventional methods currently takes approximately 5 minutes. However, this amount of time is often not available in a dynamically changing intraoperative setting during cardiac surgery. Therefore, the benefits of strain analysis have not yet been routinely utilized during the intraoperative course. However, new software solutions exist that can perform strain analysis fully automatically and reduce the examination time to a few seconds. However, it remains unclear whether these fully automated analyses also function reliably intraoperatively using transesophageal echocardiography (TEE). The aim of this study is to assess the reliability of these new methods.
Eligibility Criteria
Inclusion Criteria: * Adult (≥18 years) cardiac surgery patients * Sinus rhythm * No severe valvular regurgitation * Use of General Electric (GE) echocardiography systems (Vivid S60, S70, E95) and corresponding EchoPAC software as well as TOMTEC software. Exclusion Criteria: * Inadequate image quality * Any severe heart valve regurgitation * Mechanical circulatory support systems (e.g., LVAD, Impella, ECMO)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07496424 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Transesophageal Echocardiography. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07496424 currently recruiting?
Yes, NCT07496424 is actively recruiting participants. Contact the research team at bruno.mora@meduniwien.ac.at for enrollment information.
Where is the NCT07496424 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT07496424 clinical trial?
NCT07496424 is sponsored by Bruno Mora. The trial plans to enroll 70 participants.